CYP17 gene analysis in hyperandrogenised women with and without exaggerated 17-hydroxyprogesterone response to ovarian stimulation

Journal of Endocrinological Investigation

Volumn 20, Issue 4, 1997, Pages 189-193

  Liovic M ^a   Prezelj J ^b   Kocijancic A ^b   Majdic G ^a   Komel, R ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

CYP17; Hirsutism; PCOS; PCR; SSCP

Indexed keywords

HYDROXYPROGESTERONE; STEROID 17,20 LYASE; STEROID 17ALPHA MONOOXYGENASE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENETIC DISORDER; HUMAN; HYPERANDROGENISM; OVARY POLYCYSTIC DISEASE; PROMOTER REGION; SINGLE STRAND CONFORMATION POLYMORPHISM;

EID: 1842404741     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03346901     Document Type: Article

References (17)

1. Chung B., Picado-Leonard J., Haniu M., Bienkowski M., Hall P.F., Shively J.E., Miller W.L. Cytochrome P450c17(steroid 17α-hydroxylase/17,20 lyase): Cloning of human adrenal and testis cDNAs indicates the same gene is expressed in both tissues. Proc. Natl. Acad. Sci. USA 84: 407, 1987.
2. Rosenfield R.L., Randall B.B., Cara J.F., Lucky A.W. Dysregulation of cytochrome P450c17α as the cause of polycystic ovarian syndrome. Fertil. Steril. 53: 785, 1990.
3. Adams J., Franks S., Poison D.W., Mason H.D., Abdulwahid N., Tucker M., Morris D.V., Price J., Jacobs H.S. Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone. Lancet 2: 1375, 1985.
4. Miller S.A., Dyches D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucl. Acids Res. 16: 1215, 1988.
5. Picado-Leonard J., Miller W.L. Cloning and sequence of the human gene for P450c17 (steroid 17α-hydroxylase/17,20 -lyase): Similarity with the gene for P450c21. DNA 6: 439, 1987.
6. Rumsby G., Skinner C., Lee H.A., Honour J.W. Combined 17α-hydroxylase/17,20-lyase deficiency caused by heterozygous stop codons in the cytochrome P450 17α-hydroxylase gene. Clin. Endocrinol. (Oxf.) 39: 483, 1993.
7. Yanase T., Waterman M.R., Zachmann M., Winter J.S.D., Simpson E.R., Kagimoto M. Molecular basis of apparent isolated 17,20-lyase deficiency: compound heterozygous mutations in the C-terminal region (Arg496→Cys, Gln461→Stop) actually cause combined 17α-hydroxylase/17,20-lyase deficiency. Biochim. Biophys. Acta, 1139: 275, 1992.
8. Imai T., Globerman H., Gertner J.M., Kagawa N., Waterman M.R. Expression and purification of functional human 17α-hydroxylase/17,20-lyase (P450c17) in Escherichia coli. J. Biol. Chem. 268(26): 1968.
9. Carey A.H., Waterworth D., Patel K., White D., Little J., Novelli P., Franks S., Williamson R. Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17. Hum. Mol. Genet. 3: 1873, 1994.
10. Ahlgren R., Yanase T., Simpson E.R., Winter J.S.D., Waterman M.R. Compound heterozygous mutations (Arg239→Stop, Pro342→Thr) in the CYP17 (P450c17α) gene lead to ambiguous external genitalia in a male patient with partial combined 17α-hydroxylase/17,20-lyase deficiency. J. Clin. Endocrinol. Metab. 74: 667, 1992.
11. Bogovich K., Richards J.S. Androgen biosynthesis in developing ovarian follicles: evidence that luteinizing hormone regulates thecal 17α-hydroxylase and C-17,20-lyase activities. Endocrinology 111: 1201, 1982.
12. Eckstein B., Greenbaum O., Cohen S. Kinetic studies on ovarian C-17,20-lyase activity: effect of lutenizing hormone surge. Endocr. Rev. 117: 2376, 1985.
13. Azziz R., Zacur A. 21-hydroxylase deficiency in female hyperandrogenism: screening and diagnosis. J. Clin. Endocrinol. Metab. 69: 577, 1989.
14. Pang S., Lerner A.J., Stoner E., Levine L.S., Oberfield S.E., Engel I., New M.I. Late-onset adrenal steroid 3β-hydroxysteroid dehydrogenase deficiency. A cause of hirsutism in pubertal and postpubertal women. J. Clin. Endocrinol. Metab. 60: 428, 1985.
15. Rodin A., Thakkar H., Taylor N., Clayton R. Hyperandrogenism in polycystic ovary syndrome. Evidence of dysregulation of 11β-hydroxysteroid dehydrogenase. N. Engl. J. Med. 330: 460, 1994.
16. Stewart P.M., Shackelton C.H.L., Beastall G.H., Edwards C.R.W. 5α-reductase activity in polycystic ovary syndrome. Lancet 335: 431, 1990.
17. Mauvais-Jarvis P. Regulation of androgen receptor and 5α-reductase in the skin of normal and hirsute women. J. Clin. Endocrinol. Metab. 15: 307, 1986.